AstraZeneca is looking for partnerships in Science & Technology
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. They discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
Their research has breadth, and depth and focuses on disease areas where AstraZeneca and their partners can make the most meaningful impact on patients’ lives. Innovative Medicine’s Units (iMeds) are responsible for driving research from discovery to early development in their core therapeutic areas, while New Opportunities group looks for strategic areas of focus outside their core disease areas.
Science & Technology
The Science and Technology team works across therapeutic areas and functions to identify, evaluate, and secure opportunities in key areas of technology that will enhance the quality, effectiveness and productivity of our research.
Key areas of interest include
- predictive safety and predictive efficacy platforms,
- target validation tools and technologies,
- novel HTS/lead generation approaches,
- novel chemical libraries with evidence of biological relevance,
- stem cell biology and,
- novel technologies for antibodies and vaccines.